spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:   Novan 

 HSMN NewsFeed - 24 Feb 2021
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jun 2017
Novanta to Acquire World of Medicine for €115 Million in Cash
Devices Surgery Mergers & Acquisitions
 HSMN NewsFeed - 24 Mar 2017
Richard Peterson Joins Sienna Biopharmaceuticals As Chief Financial Officer
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 7 Oct 2015
Novan Appoints Chief Financial Officer and Chief Commercial Officer to Leadership Team
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 30 Mar 2015
Novan Secures $50 Million Private Financing
Biopharmaceuticals Dermatology Venture Capital
 HSMN NewsFeed - 19 Apr 2007
Novacea Acquires Worldwide Development and Commercialization Rights for Its Oncology Candidate AQ4N
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 24 Jan 2007
Merck Serono Has Initiated the ONWARD Study to Evaluate Oral Cladribine as Add-on Treatment for Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 16 Jan 2007
Merck Serono Completes Patient Enrollment in CLARITY Phase III Pivotal Clinical Trial of Oral Cladribine
Biopharmaceuticals Neurology
 HSMN NewsFeed - 12 Dec 2006
Serono Announces Initiation of the Reflex Trial to Evaluate New Formulation of Rebif(R) in Patients at Risk of Developing Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 28 Sep 2006
One-year Data From Phase III Trial Show That New Formulation of Rebif(r) Offers Substantial Improvement in Tolerability and Immunogenicity Profiles
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Jul 2006
European Commission Approves Revision of Therapeutic Indication for Rebif(R)
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 12 Apr 2006
Teva Announces Approval of Mitoxantrone Hydrochloride Injection USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 11 Apr 2006
American Pharmaceutical Partners Adds to Its Broad Oncology Portfolio with the Approval of Mitoxantrone Injection, USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 11 Apr 2006
Bedford Laboratories(TM) to Begin Shipping Mitoxantrone Injection USP
Biopharmaceuticals Generics
 HSMN NewsFeed - 11 Apr 2006
Mayne Announces FDA Approval of Mitoxantrone
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 4 Apr 2006
Serono Submits New Formulation of Rebif(R) for Approval in the United States and in Europe
Biopharmaceuticals FDA Neurology
 HSMN NewsFeed - 17 Jan 2006
Xanthus Initiates Phase 2 Clinical Trial with Symadex in Patients with Metastatic Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jan 2006
Xanthus Initiates Phase 2 Clinical Trial with Symadex in Women With Metastatic Breast Cancer
Biopharmaceuticals Oncology
Return to NewsFeed  

 Additional items found! 58

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 58 additional stories matching:
Novan
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.